Operating Sales Margin: Immunocore Holdings (IMCR)

Corporate company logo of Immunocore Corp (IMCR)

While a steady inflow of funds may seem debatable, tracking the operating margin confirms the resilience of the Immunocore Holdings plc (IMCR) business. Current profitability, where -6.80 is the relevant metric value, is based on sales of KIMMTRAK for the treatment of uveal melanoma. Revenues also rely on T-cell receptors for oncology. Medical recognition of these innovations ensures the long-term protection of cash flows.

IMCR: immunocore.com Operating Profit Rate 07/04/2022 - 11/20/2026

Immunocore Holdings plc - analytical breakdowns and key metrics (IMCR)

- company stock exchange capitalization indicators:
Basic company analysis:IMCR, Immunocore
Core merchandise of Immunocore Corp

The monopoly status of its uveal melanoma treatment provides Immunocore Holdings plc (IMCR) with significant pricing power. This metric measures the operating profit margin as a percentage of revenue, excluding the impact of taxes and debt obligations. The trend in operating profit percentage demonstrates management's ability to convert revenue into actual income. A stable trend confirms the effectiveness of cost controls while maintaining maximum therapy pricing. This justifies the resilience of the business's fundamental valuation.

Who Immunocore Holdings plc competes with

Operating Sales Margin IBRX|JANX - Operating Profitability Margin|Operating Sales Margin RCUS (Arcus Bio)|Operating Profit Ratio ZYME|Operating Margin TNGX (Tango Therapeutics, Inc.)|Operating Profit Rate IOVA|immatics.com - Operating Margin|Operating Return on Sales Xencor Inc.|Compass Therapeutics (CMPX) - Operating Profitability|Replimune Group, Inc. - Operating Profit Rate|LYEL (lyell.com) - Operating Margin|Operating Margin Innate Pharma SA|Operating Profitability pyxisoncology.com (PYXS)|CGEN: Operating Profit Margin|IO Biotech Inc - Operating Sales Margin|sutrobio.com (STRO) - Operating Return on Sales|INKT - Operating Profitability|werewolftx.com (HOWL) - Operating Sales Margin|Immix (IMMX) - Operating Profitability|ALXO (ALX Oncology Holdings) - Operating Profitability|Operating Sales Margin CUE|PDS Biotechnology Corporation (PDSB) - Profitability of Operations|Operating Profitability Sonnet BioTherapeutics Holdings Inc. (SONN)|Operating Margin MAIA Biotechnology Inc (MAIA)|Operating Profitability Liminatus Pharma LIMN|Operating Profit Rate LVTX|NXTC: Operating Sales Margin|leaptx.com - Operating Profit Ratio|INTS: Operating Margin|Sensei Biotherapeutics Inc - Operating Profit Rate|Operating Sales Margin TOVX|Return on Sales by Operating Profit GRTS (Gritstone bio, Inc.)|Operating Sales Margin KA (kinetabio.com)|NEXI - Operating Return on Sales|Turnstone Biologics - Operating Sales Margin|Profitability of Operations Vaccinex Inc. (VCNX)|harpoontx.com - Operating Margin